___

• Rosen HR. Clinical practice. Chronic hepatitis C infection. N Engl J Med 2011; 364:2429-2438. Armstrong GL, Wasley A, Simard EP, et al. The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Ann Intern Med 2006; 144:705-714.
• Wang CC, Krantz E, Klarquist J, et al. Acute hepatitis C in a contemporary US cohort: modes of acquisition and factors influencing viral clearance. J Infect Dis 2007; 196:1474-1482.
• Baldo V, Baldovin T, Trivello R, Floreani A. Epidemiology of HCV infection. Curr Pharm Des 2008; 14:1646-1654.
• Akcam FZ, Uskun E, Avsar K, Songur Y. Hepatitis B virus and hepatitis C virus seroprevalence in rural areas of the southwestern region of Turkey. Int J Infect Dis 2009; 13:274-284.
• Dursun M, Ozekinci T, Ertem M, et al. Prevalence of Hepatitis C in adults in the south-eastern region of Anatolia: a community-based study. Hepatol Res 2004; 29:75-80.
• Yildirim B, Barut S, Bulut Y, et al. Seroprevalence of hepatitis B and C viruses in the province of Tokat in the Black Sea region of Turkey: A population-based study. Turk J Gastroenterol 2009; 20:27-30.
• Maher L, Li J, Jalaludin B, et al. Impact of a reduction in heroin availability on patterns of drug use, risk behaviour and incidence of hepatitis C virus infection in injecting drug users in New South Wales, Australia. Drug Alcohol Depend 2007; 89:244-250.
• Burt RD, Hagan H, Garfein RS, et al. J Trends in hepatitis B virus, hepatitis C virus, and human immunodeficiency virus prevalence, risk behaviors, and preventive measures among Seattle injection drug users aged 18-30 years, 1994-2004. Urban Health 2007; 84:436-454.
• Negro F, Alberti A. The global health burden of hepatitis C virus infection. Liver Int 2011; 31:1-3.
• Porto-Espinoza L, Cuadra-Sanchez C, Moronta R, Monsalve-Castillo F, Callejas-Valero D. Immune evasion mechanisms of hepatitis C virus. Invest Clin 2006; 47:71-82.
• Cooper C. Hepatitis C Treatment Highlights from AASLD 2011. Clin Infect Dis. 2012; Apr 4. [Epub ahead of print]
• Muhlberger N, Schwarzer R, Lettmeier B, et al. HCVrelated burden of disease in Europe: a systematic assessment of incidence, prevalence, morbidity, and mortality. BMC Public Health 2009; 9:34.
• Krekulova L, Rehak V, Strunecky O, Nemecek V. Current situation and trends in the hepatitis C virus genotype distribution among injecting drug users in the Czech Republic. Epidemiol Mikrobiol Imunol 2009; 58:84-89.